Angion Biomedica Corp. (ANGN)
Angion Biomedica Statistics
Share Statistics
Angion Biomedica has 30.11M shares outstanding. The number of shares has increased by 0% in one year.
| 30.11M |
| 0% |
| 0% |
| n/a |
| n/a |
| 178 |
| 1.82% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Angion Biomedica.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
| 0 |
| 0 |
| 0 |
| -0.18 |
| -0.11 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $767,000 |
| $-18,566,666.67 |
| 3 |
| 0 |
| n/a |
Taxes
| 16.89M |
| 0% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.6, so Angion Biomedica's price volatility has been higher than the market average.
| 0.6 |
| n/a |
| 0.71 |
| 0.82 |
| 71.81 |
| 9,772 |
Income Statement
In the last 12 months, Angion Biomedica had revenue of 2.3M and earned -55.7M in profits. Earnings per share was -1.85.
| 2.3M |
| 2.3M |
| -30.44M |
| -55.7M |
| -20.12M |
| -28.82M |
| -1.85 |
Balance Sheet
The company has 50.49M in cash and 3.71M in debt, giving a net cash position of 46.78M.
| 50.49M |
| 3.71M |
| 46.78M |
| -253.94M |
| 30.99M |
| 8.45M |
Cash Flow
In the last 12 months, operating cash flow was -32.69M and capital expenditures -66K, giving a free cash flow of -32.76M.
| -32.69M |
| -66K |
| -32.76M |
| 0 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| -1322.73% |
| -1423.73% |
Dividends & Yields
ANGN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jun 2, 2023. It was a backward split with a ratio of 1:10.
| Jun 2, 2023 |
| backward |
| 1:10 |
Scores
| -7.9 |
| 2 |